Cori Gorman

Cori Gorman, Ph.D., has more than 25 years of experience in the biotechnology and pharmaceutical industry including gene therapy, cell therapy, cancer vaccines, biologics and biosimilars. She brings an outstanding record of achievement in basic research and drug development with over 24,000 citations, 9 issued patents in the fields of gene expression and delivery and gene therapy and the development of a number of marketed biologics. As experienced entrepreneur, Cori has co-founded 2 start-ups and has extensive experience in raising capital, strategic planning, and partnership building. As a Principal Consultant / Senior Director of CMC and regulatory affairs at Biopharma Excellence, she is playing a key role to help biopharmaceutical partners realize the potential of their innovation from discovery to market approval in the field of gene therapy, autologous and allogeneic cell therapy and cancer vaccines.